ClinicalTrials.Veeva

Menu

Treatment of Corneal Wounds Emergencies During the COVID-19 Shutdown: Absorbable 10-0 Vicryl Sutures as a Valuable Strategy.

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Eye Trauma

Treatments

Other: data collection

Study type

Observational

Funder types

Other

Identifiers

NCT04733846
IRBN202021/CHUSTE

Details and patient eligibility

About

Vicryl (polyglactin) 10-0 resorbable suture is rarely used, little known to ophthalmologists but may offer therapeutic and practical advantages in eligible cases of corneal trauma, particularly during a COVID-19 pandemic.

This has imposed new sanitary restrictions : limited access to the operating room in ophthalmology only for functional emergencies and a drastically reduced capacity for external consultations in favor of teleconsultation. The aim of this study is to evaluate the Vicryl 10-0 (polyglactin 910) resorbable monofilament suture in corneal trauma, rather than classic Nylon 10-0: structural and functional results, and adaptation of postoperative follow-up during a sanitary crisis period.

Enrollment

10 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Corneal penetrating injury and/or lamellar laceration

Exclusion criteria

  • Corneal Penetrating injury trauma requiring necessarily ONLY Nylon 10-0
  • Traumatism requiring necessarily a cryopreserved human amniotic membrane (for example)
  • Traumatism eligible for biological glue (long-axis wound < 2 mm)

Trial design

10 participants in 1 patient group

corneal trauma sutured with Vicryl 10-0 monofilament
Description:
corneal trauma sutured with Vicryl 10-0 monofilament will be included. They will have data collection of medical records.
Treatment:
Other: data collection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems